Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

Chronic kidney disease can cause hair loss, which may be related to zinc deficiency or certain medications, and sometimes hair grows back when the underlying issue is treated.

A patient lost all their hair while on rheumatoid arthritis medication.

ADHD stimulant medications might be linked to a specific type of hair loss called Alopecia Universalis.

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.

Nonionic liposomes are the best for delivering genes to skin cells.

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

Various drugs caused different skin reactions, including allergic and inflammatory responses.

Some medications might reverse gray hair, especially those that reduce inflammation or stimulate pigment production, and vitamin B might help.

TNF-alpha inhibitors can cause various immune-related skin issues.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

A woman developed psoriasis after taking certolizumab pegol, improving after stopping the drug and starting other treatments.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Nanocarriers could improve how drugs are delivered through the skin but require more research to overcome challenges and ensure safety.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Many research paper titles in dermatology journals lack scientific precision.

The supplement highlighted advancements and challenges in plastic and reconstructive surgery, including the impact of smoking, chemotherapy, and new treatments like Tafluprost for hair loss.

Chitosan, a natural substance, can be used to create tiny particles that effectively deliver various types of drugs, but more work is needed to improve stability and control of drug release.

Dissolving microneedles show promise for delivering medication through the skin but face challenges like manufacturing complexity and regulatory hurdles.

New therapies are being developed that target integrin pathways to treat various diseases.

Gene therapy shows promise for healing chronic wounds but needs more research to overcome challenges.

MSCs and their exosomes may speed up skin wound healing but need more research for consistent use.

Nitric Oxide has potential in medicine, especially for infections and heart treatments, but its short life and delivery challenges limit its use.